Trending Now

IMF Bentham teams with Boies Schiller Flexner to provide US$30M capital and legal representation to parties with Vietnamese cross-border disputes

By John Freund |
16 APRIL 2019:  Leading international dispute financier, IMF Bentham Limited (ASX:IMF) and renowned global litigation and arbitration firm Boies Schiller Flexner LLP (BSF) announce a collaboration to provide up to US$30 million in funding capital for cross-border disputes with a Vietnamese connection. This world-first collaboration combines IMF Bentham’s financial support with BSF’s unmatched legal and Vietnam expertise to benefit foreign investors or Vietnamese businesses in Vietnam-related disputes, including international arbitration or US/UK litigation.

Why Vietnam?

Vietnam is poised to become Asia’s next economic powerhouse. It has one of the fastest-growing economies in the world and a population approaching 100 million. It is also attracting record foreign investments in major infrastructure, manufacturing, real estate, and energy projects. Leading local businesses are also beginning to expand their operations abroad. When disputes arise, they typically involve multi-national parties and multi-jurisdictional proceedings. These disputes are complex and costly, and they require legal representation with a mix of local, regional and international expertise. Very few international players offer such expertise or the flexible sources of dispute finance that litigation funding offers.  Until now.

What does the IMF-BSF arrangement mean for clients?

Together, IMF and BSF bring the capital and know-how required to pursue complex and high stakes Vietnam related claims. The arrangement brings clients:

  • fast and streamlined funding assessment (within 4 weeks)
  • legal representation by one of the world’s leading trial and arbitration law firms with unique Vietnam expertise
  • risk-free recoveries (neither BSF nor IMF Bentham recover any costs unless the claim is successful)
How will the arrangement work?

IMF will fund preliminary investigations into potential claims and also subsidize BSF’s legal fees and external expenses (e.g., expert witnesses) for claims that proceed. Funding arrangements will be tailored for each specific case.

IMF’s Chief Investment Officer (Asia), Tom Glasgow, said: IMF and BSF have had a strong working relationship on funded matters, and our US division successfully funded a matter with Mr Tran that resolved in 2016. Our new arrangement with BSF responds to increasing demand for legal representation in cross-border disputes involving Vietnamese parties and assets. It also reflects the growing appetite for third-party finance as a tool for resolving disputes in Asia.

Luan Tran, Partner at BSF said: “I lead a unique practice which combines the Vietnamese perspective (jurisdictional know-how, local contacts and language) with BSF’s global disputes expertise.  I recently lived and worked in Vietnam and Asia and regularly travel for work there. I have an intimate knowledge of the market. This collaboration with IMF allows foreign investors doing business in Vietnam, as well as Vietnamese companies doing business internationally, to pursue cases prosecuted by a leading law firm that previously might have been beyond reach for cost reasons.” 

Quyen Ta, Partner at BSF said: “I have represented the top companies based in Asia and the United States in their highest-stakes intellectual property, class action, and trade secrets disputes—whether in state or federal courts, or in international arbitrations.  Clients appreciate that they can come to BSF for their Southeast Asian disputes, be able to retain experienced trial lawyers like me and Luan who are culturally and linguistically competent, and have access to a reputable litigation funding source.”

ABOUT IMF BENTHAM

IMF is one of the leading global litigation funders, headquartered in Australia and with offices in the US, Singapore, Canada, Hong Kong and the UK. IMF has built its reputation as a trusted provider of innovative litigation funding solutions and has established an increasingly diverse portfolio of litigation funding assets.

IMF has a highly experienced litigation funding team overseeing its investments. We have a 90% success rate over 184 completed investments and have recovered over A$1.4 billion for clients since 2001.

For further information please see Tom Glasgow and www.imf.com.au.

As Chief Investment Officer (Asia), Tom Glasgow leads the Asian investment activities and business expansion for IMF Bentham. Prior to joining IMF Bentham, Tom was a senior member of market leading international arbitration and disputes practice in Asia, where he handled complex multi-jurisdictional commercial matters for leading global businesses across a range of sectors.

ABOUT BOIES SCHILLER FLEXNER

Boies Schiller Flexner is a firm of internationally recognized trial lawyers, crisis managers and strategic advisors known for their creative, aggressive and efficient pursuit of success for the firm’s clients. The firm has an established record of taking on and winning complex, ground-breaking and cross-border matters in diverse circumstances and industries for many of the world’s most sophisticated companies. The firm has 15 offices located throughout the United States and in London. It is also the only AmLaw firm with two Vietnamese-speaking partners with extensive first-chair trial and arbitration experience.

For further information please see Luan TranQuyen Ta and Boies Schiller Flexner.

Luan Tran has more than 20 years of experience in international arbitration. He has handled, both as counsel and arbitrator, some of the most significant Vietnam-related international arbitration matters. He co-authored the Vietnam chapter for two major international publications. Prior to BSF, Luan was an international arbitration partner at a prominent Vietnam-based law firm. He was also an early member of the international arbitration practice at Quinn Emanuel Urquhart & Sullivan. He is currently a member of the AAA-ICDR’s Council and Asia Advisory Committee.He has three law degrees, including one from Harvard Law School.

Quyen Ta co-leads Boies Schiller Flexner’s Bay Area practice. She is a graduate of UC Berkeley School of Law and is a highly sought-after trial lawyer who has more than 15 years of experience litigating high-stakes disputes in the United States and in international arbitrations. Her practice has included representing top Asian-based companies, such as Taiwan Semiconductor Manufacturing Company, in its most sensitive cross-border matters, and which has included litigating jurisdictional issues throughout the United States. Her current clients include top Fortune companies, as well as Asian-based companies such as VNG Corporation (Vietnam) and Rakuten (Japan).

About the author

Announcements

View All

ALFA Welcomes Mackay Chapman as Newest Associate Member

By Harry Moran |

In a post on LinkedIn, The Association of Litigation Funders of Australia (ALFA) announced that it is welcoming Mackay Chapman as its newest Associate Member. Mackay Chapman becomes the 12th Associate Member of ALFA, following the inclusion of Litica in April of this year.

Mackay Chapman is a boutique legal and advisory firm, specialising in high-stakes regulatory, financial services and insolvency disputes. The Melbourne-based law firm was founded in 2016 by Dan Mackay and Michael Chapman, who bring 25 years of experience in complex disputes to the business.More information about Mackay Chapman can be found on its website.

Read More

CASL Targets Australian Investors in Launch of New $150M Litigation Fund

By Harry Moran |

Leading Australian litigation funder CASL today launched a $150 million fund giving local investors the opportunity to participate in funding of selected new class actions including product liability and other mass consumer claims, commercial litigation and insolvency claims. 

CASL Fund 2 is expected to appeal to Australian sophisticated investors seeking exposure to a truly alternative asset class with attractive risk-adjusted returns and a capital-protected option. The fund is well suited to high-net worth individuals, family offices and foundations seeking to diversify into uncorrelated ESG assets. 

Co-founded in 2020 by two of Australia’s most experienced litigation funders, John Walker and Stuart Price, CASL has quickly established a reputation as an astute backer of legal claims in the competitive Australian market. The two completed actions filed with the backing of CASL’s inaugural $156 million fund since 2022 have returned 165% to investors; another 11 actions are in progress. 

Considered a pioneer of litigation funding in Australia, CASL Executive Chair John Walker co-founded IMF Bentham, now Omni Bridgeway, in 1998 while CASL CEO Mr Price was CEO of Litigation Lending Services for six years prior to co-founding CASL. 

Mr Price said litigation funding had an important role to play in levelling the legal playing field for victims of corporate or government misconduct, and investors were important partners in this process. 

“In global terms Australia is a receptive jurisdiction for the filing of group claims and funded actions but there is increasingly a premium on funders with proven expertise in sourcing and qualifying claims, and managing them to a successful resolution,” Mr Price said. 

“CASL brings that – our team has a proven record for deploying funds efficiently in support of worthy claims and generating strong financial outcomes for both claimants and investors. 

“We see a healthy pipeline of potential new actions in Australia with good prospects and considerable upside for investors willing to fund them. This fund will be a rare opportunity for investors to participate in a purely domestic litigation funding play backed by an experienced local team with a proven record for generating returns for investors. Early indications are we have $30 million in investor pre-commitments so there is clearly an appetite for litigation funding as an alternative asset class.” 

The combined success rate of 183 funded claims involving Mr Walker or Mr Price since 1996 is 92%. These cases have delivered settlement proceeds of $2.6 billion with an average duration of two and half years. 

The launch of CASL Fund 2 comes amid a changing landscape for class actions in Australia, with consumer actions overtaking securities actions as the leading type of funded claim, reflecting the development of effective legislation to hold large corporates to account. 

An innovative feature of the CASL Fund 2 offer is the ability of investors to elect a capital-protected allocation option with a discounted target return.

Key features of the offer include:

 CASL Fund 2: Up to $150m, Class A and Class B Units
 Class AClass B
Capital protectionYesNo
Fund term5 years
(2 years investment, 3 years harvest)
Hurdle rate per annum10%12%
Performance fee (after hurdle, fees and costs)40%25%
Management fee (% of capital commitment) per annum2%2%

Funds raised will be deployed only into new actions, with all existing funded matters funded by CASL Fund 1. No distinction will be made between Class A and B funds for the purposes of funding actions. 

An estimated $200m to $300m is deployed by litigation funders supporting legal claims in Australia, excluding law firms’ funding of actions from their own balance sheets. The most active sources of funding for Australian actions are based offshore and include hedge funds and specialist asset managers, many domiciled in tax-friendly jurisdictions such as the Cayman Islands and Channels Islands, attracted to Australia’s relatively receptive environment for group claims. 

CASL’s Fund 2 will be an Australian-domiciled unit trust. Bell Potter is lead manager for the CASL Fund 2 capital raise. 

Mr Price said: “Agility and responsiveness are important in selecting claims and bringing litigation – being based locally, CASL has the advantage of being able to move and make decisions quickly when required.” 

To coincide with the fundraise CASL announced that Ian Stone, former Group Managing Director and CEO of RAA, would join the Board of CASL’s Trustee entity CASL Funder Pty Limited. Tania Sulan, former Managing Director and Chief Investment Officer - Australia for Omni Bridgeway will also join the CASL Investment Committee. Visit www.casl.com.au for more information about CASL Fund 2.

Read More

Almaden Announces Litigation Financing of up to $9.5 million

By Harry Moran |

Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) is pleased to announce that further to its press release of June 17, 2024, it has confirmed non-recourse litigation funding in the amount of up to US$9.5 million to pursue its international arbitration proceedings against the United Mexican States (“Mexico”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”). The Company has also agreed with Almadex Minerals Ltd. (“Almadex”) to an extension to the maturity of its gold loan, and a litigation management agreement to help streamline corporate management of the arbitration process.

  • Non-recourse funding secured to pursue international arbitration proceedings against Mexico;
  • Globally leading counterparty validates quality of legal claims;
  • Gold loan maturity pushed out from March 31, 2026 to March 31, 2030;
  • Litigation Management Agreement streamlines corporate management of the arbitration proceedings to save money and time.

Litigation Financing

The Company has signed a litigation funding agreement (“LFA”) with a leading legal finance provider. The facility is available for immediate draw down for Almaden to pursue damages against Mexico under the CPTPP resulting from Mexico’s actions which blocked the development of the Ixtaca project and ultimately retroactively terminated the Company’s mineral concessions, causing the loss of the Company’s investments in Mexico.

The LFA provides funding which is expected to cover all legal, tribunal and external expert costs of the legal claims, as well as some corporate operating expenses as may be required. The funding is repayable in the event that a damages award is recovered from Mexico, with such repayment being a contingent entitlement to those damages.

The financing follows extensive due diligence by the finance provider. The financing size as well as the quality of the provider is testament to the strength of the Company’s legal claims against Mexico.

Gold Loan Amendment

The Company is also pleased to report that it has agreed with Almadex to extend the maturity of the gold loan (see press release of May 14, 2019) from March 31, 2026 to the earlier of March 31, 2030 or the receipt by Almaden or its subsidiary of any amount relating to its legal claims against Mexico.

In return for this amendment, in addition to its obligation to repay the gold loan, the Company has agreed to pay Almadex 2.0% of the gross amount of any damages award that Almaden may receive as a result of the legal claims, such repayment to be subordinate to amounts due under the LFA, and any additional legal and management fees.

Litigation Management Agreement

Finally, the Company has agreed with Almadex and its Mexican subsidiary to streamline the management of the arbitration proceedings by entering into a Litigation Management Agreement (“LMA”). Under the LMA, Almaden will bear the up-front costs of the arbitration and provide overall direction to the arbitration process for itself and its subsidiaries, as well as Almadex and its subsidiaries, with certain limitations. Almadex will remain a party to the arbitration and continue in its cooperation and support of the process. As noted above, Almaden has already secured litigation funding in the amount anticipated to be needed to fully prosecute the arbitration proceedings.

Should the arbitration proceedings result in an award of damages, the pro rata portion of those damages, if any, which may be attributable to Almadex from the 2.0% NSR royalty it held on the Ixtaca project will be determined. Almadex’s award will consist of this pro rata portion, less its pro rata share of the costs of pursuing the legal claims, including the financing costs (the “Almadex Award”). Almadex will compensate Almaden in the amount of 10% of the Almadex Award in exchange for managing the claim proceedings.

Safe Harbor Statement

Certain of the statements and information in this news release constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian provincial securities laws. All statements, other than statements of historical fact, are forward-looking statements or information. Forward-looking statements or information in this news release relate to, among other things, the total potential cost of the legal claims and the sufficiency of the money available under the LFA to cover these costs, the ability of the LMA to streamline corporate management of the legal claims, and the result and damages arising from the Company’s request for arbitration.

These forward-looking statements and information reflect the Company’s current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable by the Company, are inherently subject to significant legal, regulatory, business, operational and economic uncertainties and contingencies, and such uncertainty generally increases with longer-term forecasts and outlook. These assumptions include: stability and predictability in Mexico’s response to the arbitration process under the CPTPP; stability and predictability in the application of the CPTPP and arbitral decisions thereon; the ability to continue to finance the arbitration process, and continued respect for the rule of law in Mexico. The foregoing list of assumptions is not exhaustive.

The Company cautions the reader that forward-looking statements and information involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements or information contained in this news release. Such risks and other factors include, among others, risks related to: the application of the CPTPP and arbitral decisions thereon; continued respect for the rule of law in Mexico; political risk in Mexico; crime and violence in Mexico; corruption in Mexico; uncertainty as to the outcome of arbitration; as well as those factors discussed the section entitled "Risk Factors" in Almaden's Annual Information Form and Almaden's latest Form 20-F on file with the United States Securities and Exchange Commission in Washington, D.C. Although the Company has attempted to identify important factors that could affect the Company and may cause actual actions, events or results to differ materially from those described in forward-looking statements or information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that our forward-looking statements or information will prove to be accurate. Accordingly, readers should not place undue reliance on forward-looking statements or information. Except as required by law, the Company does not assume any obligation to release publicly any revisions to on forward-looking statements or information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Read More